What is it about?
Large group study under the acronym CRASH 2 dealing with effect of tranexemic acid for the prevention of trauma related DIC
Featured Image
Why is it important?
Very important conclusion related to the management of trauma patients.
Perspectives
Read the Original
This page is a summary of: The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial, The Lancet, March 2011, Elsevier,
DOI: 10.1016/s0140-6736(11)60278-x.
You can read the full text:
Contributors
The following have contributed to this page